Cite

HARVARD Citation

    Rugo, H. et al. (2018). Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. Annals of oncology. pp. 888-894. [Online]. 
  
Back to record